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Background: Sensory hyperreactivity (SHR) is one explanation for airway symptoms induced by chemicals and
scents. Little is known about health-related quality of life (HRQOL) and coping, in this group of patients. A study
was done in patients with SHR to (1) compare the Nottingham Health Profile (NHP) and the Short-Form 36 Health
Survey (SF-36) in regard to their suitability, validity, reliability, and acceptability; (2) evaluate how the patients cope
with the illness; (3) assess whether there are differences between women and men with respect to HRQOL and
coping; and (4) assess whether there are differences between patients and normative data with respect to HRQOL
and coping.
Methods: A total of 115 patients (91 women) with SHR were asked to answer five questionnaires: a study-specific
questionnaire, the Chemical Sensitivity Scale for Sensory Hyperreactivity (CSS-SHR), the NHP, the SF-36, and the
Jalowiec Coping Scale-60.
Results: Eighty-three patients (72%; 70 women) completed all questionnaires. The SF-36 scores were less skewed and
more homogeneously distributed and showed fewer floor and ceiling effects than the NHP scores. The SF-36 was
also discriminated better between patients with high and low CSS-SHR scores. The reliability standard for both
questionnaires was satisfactory. There were no gender differences in HRQOL. Patients with SHR had significantly lower
HRQOL scores than the normative data in comparable domains of the NHP and the SF-36: emotional reactions/mental
health, energy/vitality, physical mobility/functioning, and pain/bodily pain. In social isolation/functioning, the results
were different; the NHP scores were similar to the normative data and the SF-36 scores were lower. The most
commonly used coping styles were optimistic, self-reliant, and confrontational. Women used optimistic coping more
than men. Compared with the normative group, patients with SHR used confrontational and optimistic coping more
and emotive coping less.
Conclusions: The current findings showed that both the NHP and the SF-36 were reliable instruments; but the results
suggest that the SF-36 is a more sensitive instrument than the NHP for elucidating HRQOL in patients with SHR. Patients
with SHR experienced a poor HRQOL and they followed the Western tradition of preferring problem-focused coping
strategies to palliative and emotive strategies.
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Sensory hyperreactivity (SHR) was found to be one explan-
ation for airway symptoms induced by chemicals and
scents. An objective test method called the capsaicin inhal-
ation cough test and a questionnaire, the Chemical Sensitiv-
ity Scale for Sensory Hyperreactivity (CSS-SHR) have been
developed to identify patients with SHR, and a high CSS-
SHR score is directly related to capsaicin sensitivity [1,2].
The symptoms of SHR often mimic asthma and/or allergy,
but in most cases asthma and allergy tests are negative, and
asthma or allergy medication has no effect. The most com-
mon symptoms reported by the patients are cough, heavy
breathing, difficulty getting air, chest weight, phlegm,
hoarseness, stuffy nose, and eye irritation. Some patients
also reported more general symptoms such as sweating,
dizziness, and headache. Common trigger factors are per-
fume, flowers, coloured paints, cigarette smoke, and car ex-
haust fumes, as well as cold air and exercise [3]. More than
6% of the adult population in Sweden has been estimated
to have SHR, where the SHR diagnosis was based on a high
CSS-SHR score in combination with a positive reaction to
the capsaicin inhalation cough test [2].
Health-related quality of life (HRQOL) is a measure of
how diseases and symptoms affect health, well-being, and
the ability to function in daily life. It includes several di-
mensions: physical function, role function, e.g., work,
home management, social function, psychological func-
tion, and general well-being [4]. HRQOL is measured by
means of standardized questionnaires, which can be gen-
eric or disease-specific. Generic instruments cover a wide
range of dimensions and are applicable in a wide variety of
conditions. Disease-specific instruments, on the other
hand, are designed for a particular patient population. The
choice of instrument depends on the approach of the
study, and it is important to use instruments that are both
reproducible and valid [5]. Generic HRQOL instruments
need to satisfy different criteria to be suitable for measur-
ing health outcomes in clinical settings and research. One
important criterion is that the instrument should be vali-
dated (assessed to ensure it measures what it purports to
measure). One aspect of validity refers to construct valid-
ity (the ability of an instrument to distinguish between
known groups). Another important characteristic is reli-
ability (the degree to which an instrument is free from
random error and all items measure the same underlying
attribute). Further the instrument must be acceptable to
patients, and quick and easy to use [6]. The Nottingham
Health Profile (NHP) and the Short-Form 36 Health Sur-
vey (SF-36) are both generic instruments that address
multidimensional aspects of HRQOL [7].
The NHP questionnaire has been used in several studies
of chronic illnesses and conditions [8,9]. The question-
naire was developed in 1980 at Nottingham University
(UK) for measuring subjective health status [10]. Somelimitations have been shown with regard to sensitivity. Pa-
tients with milder symptoms tend to score zero (no prob-
lems) or near to zero, and the questionnaire seems,
therefore, to be unsuitable for use in examining improve-
ments [11]. The SF-36 questionnaire was developed 10
years later from a questionnaire known as the Medical
Outcome Study General Health Survey Instrument [12]. It
has also been used in several studies of various chronic ill-
nesses and conditions [8,9,13]. A limitation has been
found in the bodily pain dimension in SF-36; it only corre-
lates moderately to a pain scale that quantifies pain sever-
ity in patients with hip and knee osteoarthritis [14].
Two previous studies, which used the NHP, have de-
scribed the HRQOL in patients with SHR [3,15]. The con-
dition has great influence on several aspects of daily life
and the reduced HRQOL did not change during a five-
year period [3]. Millqvist el al. showed that patients with
SHR with reduced HRQOL were more sensitive to inhaled
capsaicin [15]. Using a qualitative approach, Larsson et al.
studied a group of patients with SHR and how they handle
their problems. The patients felt that there was a lack of
understanding from others, felt limitations in daily life and
were afraid that the symptoms would indicate a problem
that would become a serious disease [16]. Söderholm et al.
reported similar results in patients with SHR in regard to
their limitation in participating in society and lack of un-
derstanding from others [17]. Similar results have been
found in patients with chemical sensitivity [also called
multiple chemical sensitivity (MCS)]; the results showed a
lack of access regarding education, use of public transpor-
tation, visits to restaurants, movies, friends, medical care,
and problems at work [18-20]. Further, according to
Lipson, people have difficulties living with MCS. They
have to face social, attitudinal, and logistical barriers. So-
cial suffering increased for people with MCS because their
relationships with family, friends, school or work, and
physicians were negatively affected [21].
When people become patients, they enter a stressful situ-
ation. Coping is the response that aims to reduce the level
of stress. Coping is an attempt to manage situations that
produce discomfort, and it is a function of both the envir-
onment and the individual’s cognitive appraisal of the situ-
ation. According to this theory, the individual and the
situation cannot be separated: coping is not outcome
dependent; rather it is simply the attempt to manage the
situation [22]. The Jalowiec Coping Scale-60 (JCS-60) was
developed in 1987 to measure the process of coping [23]. It
has been used in several studies in different conditions
[24,25], and studies show that women may use different
kinds of coping strategies than men [26,27]. Depending on
their function, coping strategies can be classified in two
major categories. One is problem-focused, in which the pa-
tient deals directly with the problem, e.g. information, seek-
ing, and goal setting. The other is emotion-focused coping,
Kristofferzon and Ternesten-Hasséus Health and Quality of Life Outcomes 2013, 11:182 Page 3 of 10
http://www.hqlo.com/content/11/1/182in which the patient deals with the emotions associated
with the stress, e.g., worry or depression. According to
Lazarus, in Western culture there is a strong tendency to
regard problem-focused coping as being more successful
and effective than emotive coping [22].
Nordin et al. studied coping strategies in a group of pa-
tients who considered themselves intolerant to odorous/
pungent chemicals. The most commonly used and effective
coping strategies were avoiding odorous environments,
and asking people to limit their use of odorous substances.
Other strategies were to accept the situation and repriori-
tize how important things were [28]. Patients with asthma-
like symptoms describe having similar symptoms and
trigger factors as SHR-patients. Ringsberg et al. studied the
lives of a group of female patients with asthma-like symp-
toms. The patients had few coping strategies; they experi-
enced social isolation and distress and a feeling of ‘walking
around in circles’ [29]. A study with problem-based learn-
ing in patients with asthma-like symptoms showed that the
participants learned to use new coping strategies, could de-
scribe the disorder in words, and had their self-confidence
increase [30]. Larsson et al. showed that patients with SHR
cope with their symptoms by avoiding situations that they
cannot tolerate. Another way they managed difficult
situations was by disparaging the symptoms or to simply
denying them [16].
Little is known about HRQOL and which of the two
generic instruments, the NHP or the SF-36, is more
suitable for measuring HRQOL in patients with SHR.
Further, little is known about coping strategies among
patients with SHR. In addition, little is known about
gender differences and differences between normative
data in HRQOL and coping among these patients.
These issues can, however, be examined using estab-
lished questionnaires.
The aims of the present study of patients with SHR were
(1) to compare two generic quality-of-life questionnaires,
the NHP and the SF-36, regarding their suitability (in re-
spect of floor effects, ceiling effects, validity and reliability),
and acceptability (assessed by using the completion rate as
an indicator) as outcome measures of HRQOL; (2) to
evaluate how these patients cope with the illness; (3) to as-
sess whether there are differences between women and
men with respect to HRQOL and coping, and (4) to assess
whether there are differences between patients and norma-
tive data with respect to HRQOL and coping.
Methods
Study design
This study was designed as a comparative study and data
were collected using questionnaires administered to pa-
tients who had visited the clinic and been diagnosed with
SHR. All patients were selected from the medical records
at the Department of Allergology at the SahlgrenskaUniversity Hospital in Gothenburg, Sweden, between
January 2007 and October 2009.
Participants
One-hundred and fifteen patients (91 women and 24
men) fulfilled the criteria for SHR and were invited to par-
ticipate in this study. Inclusion criteria were: (1) a history
of airway symptoms induced by chemicals and scents, (2)
a positive reaction to the capsaicin inhalation test, as de-
scribed by Johansson et al. [1], (3) no sign of bronchial re-
versibility or variability according to spirometry, (4) a
negative reaction to the methacholine inhalation test, ad-
ministered according to international guidelines [31], and
(5) a negative skin prick test, with a standard panel of 10
allergen sources common to Sweden. Exclusion criteria
were allergy, rhinitis, post-nasal drip, and gastroesopha-
geal reflux disease (GERD), as were use of angiontensin-
converting enzyme inhibitor or medication for GERD
and current smoking. Informed consent was obtained
from all participants at the start of the investigation.
The study was approved by the Regional Ethical Review
Board of Gothenburg, Sweden.
Data collection
Data were collected using a study-specific questionnaire
and four standardized questionnaires [the CSS-SHR, NHP,
SF-36, and JCS-60]. The questionnaires were sent by mail
to the patients with a covering letter, an informed consent
form, and a prepaid envelope. The estimated time to
complete all five questionnaires was about 25 minutes.
The patients were reminded about the study once, within
a month, and a new letter and questionnaires were sent to
them. In some cases, patients were phoned for supple-
mentary answers. The patients were asked to answer the
questions based on their condition as experienced during
the previous month. Permission to use the instruments
was obtained from the respective copyright holders. All
data were recorded by subject number so the authors and
the statistician did not know the identity of the patients.
Questionnaires
Study-specific questionnaire
The study-specific questionnaire contains questions re-
garding demographic data (age, gender, duration of symp-
toms, smoking habits, and inducing factors).
Standardized questionnaires
CSS-SHR The CSS-SHR questionnaire was developed
from the chemical sensitivity scale in 2004 to quantify
self-reported sensitivity to chemicals and scents in the
course of daily activities. It is validated and has good re-
producibility [32]. The questions were selected from a
large number of items about odour intolerance and consist
of 11 statements/questions that are particularly sensitive
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[33]. The unweighted sum of all 11 items makes up the in-
dividual’s total CSS-SHR score, ranging from 0 to 54. A
score of ≥ 43 points is regarded as a diagnostic cut-off
value for SHR, and a high score indicates high sensitivity
to chemicals and scents [32]. In the adult Swedish popula-
tion the prevalence of such odour intolerance, defined as a
CSS-SHR score ≥ 43, has been determined to be 19%, with
an increased risk for female gender (odds ratio: 2.3) [34].
NHP The NHP is a two-part instrument. In order to com-
pare the NHP and the SF-36, only part one of the NHP was
used in this study. Part I contains 38 items covering six as-
pects of HRQOL, concerning the domains of emotional re-
actions, energy, physical mobility, social isolation, pain, and
sleep. The response alternatives for each item are ‘yes’ and
‘no’, depending on whether that item fits the individual’s
current situation. The possible score for each dimension
ranges from zero (no problems at all) to 100 (presence of
all problems within the area) [10]. The NHP has shown to
have good reliability and validity [35,36].
SF-36 The SF-36 contains 36 items covering eight health
concepts: mental health, vitality, psychical functioning, so-
cial function, bodily pain, role limitations due to physical
problems, emotional problems, and general health. The
response options used were 2-graded (1 = yes, 2 = no),
and 3-graded (1 = yes, much limited, 3 = no, not at all lim-
ited), 5-graded (1 = not at all, 5 = very much), and 6-grade
(1 = all the time, 6 = none of the time) scales. The scores
for each scale are coded, summed, and transformed into a
scale ranging from 0 (worst possible health) to 100 (best
possible health) [12,37]. In studies, the SF-36 has shown
good reliability and validity [38,39].
JCS-60 The JCS-60 was used to assess general coping
behaviour [23]. It consists of two parts (A = use, B =
effectiveness) with 60 items in each part. Each item de-
scribes a strategy a person can use to handle stress.
Strong positive correlations between part A (use) and
part B (effectiveness) for JCS-60 were demonstrated in
patients with end-stage renal disease, and in people with
kidney transplants, which may indicate that these two
parts reflects similar or the same aspects of coping
[40,41]. Therefore only part A was used in this study.
The participants were asked to think of something stress-
ful in connection with their sensitivity to chemicals and
scents and to rate how often they used the strategy, on
a 4-point scale (0= never used, 3 = often used). The
coping strategies are grouped into eight styles: optimistic,
self-reliant, confrontational, fatalistic, evasive, supportive,
palliative, and emotive. The JCS-60 has been comprehen-
sively evaluated and found to have good reliability and
validity [23,42].Statistical analysis
Descriptive statistics were used to examine the data.
Data are presented for continuous variables as mean
and standard deviation (SD) and for categorical vari-
ables as percent (%).
For comparison between groups, Fisher’s Exact Test
was used for dichotomous variables, and the Mann–
Whitney U-test and unpaired t-test were used for
continuous variables. Results were considered signifi-
cant if p < 0.05. Analysis of comparability between the
NHP and the SF-36 were calculated between the
domains that are comparable, including emotional re-
actions, energy, physical mobility, social isolation, and
pain for the NHP, and mental health, vitality, physical
functioning, social functioning, and bodily pain for the
SF-36 (Table 1). The level of correlation between the
NHP and the SF-36 was calculated among the do-
mains’ scores with the Pearson Correlation Coefficient.
To compare the mean scores per dimension between
the NHP and the SF-36 questionnaire, the NHP score
was subtracted from 100, since the scoring pattern in
this instrument works in the reverse fashion to that of
the SF-36. Hence, the score in the present study for
both the NHP and SF-36 are presented in a range
from 0 to 100 (0 = worst perceived health and 100 =
best possible health).
In order to determine suitability of the NHP and SF-
36 questionnaire to measure HRQOL, the percentages
of patients obtaining the worst possible score of 0 (floor
effect) and the best possible scores of 100 (ceiling effect)
were calculated. Further, validity of the NHP, SF-36, and
JCS-60 questionnaires were examined by the Mann–
Whitney U-test regarding the relative ability to discrim-
inate among patients with high (≥ 43 points) and low
(< 43 points) CSS-SHR scores. Reliability was expressed as
Cronbach’s coefficient alpha (α). A coefficient > 0.70 was
taken to be acceptable and satisfactory reliability [43].
Norm and reference values distributed for age and sex
based on data from larger population studies are used
for the NHP, the SF-36 and the JCS-60 questionnaires
[26,37,44].
All statistical analyses were performed using software,
StatView 5 (SAS Institute INC., Cary, NC, USA) and
SPSS 17.0 (SPSS, Inc., Chicago, IL, USA).
Results
Participant characteristics
Eighty-three (72%) patients returned the questionnaires.
Reasons for not participating were language difficulties in
5 patients (2 men) and personal reasons in 27 patients (9
men). The group mainly consisted of women. Thirteen
men (15.6%) participated in this study. The demographic
data of the study group are shown in Table 2. There were
no significant gender differences with respect to age, lung
Table 1 Different domains in the NHP and the SF-36
Domains NHP SF-36
Psychological status Emotional reactions (9 items) Mental health (5 items)
Energy (3 items) Vitality (4 items)
Physical activity Physical mobility (8 items) Physical functioning (10 items)
Social activity Social isolation (5 items) Social functioning (2 items)




Comparable domains are shown in bold.
Table 2 Characteristics of the study group
Characteristics Subjects (n=83)
Sex, Female/Male (n) 70/13
Age (years) 53.1 (11.8)
Duration of symptoms (years) 13.6 (10.2)
FEV1 % predicted 99.8 (12.9)






Chemicals and scents 100
Cold air 71.4
Exercise 70.2
Data are shown as mean and standard deviation (SD) for age, duration of
symptoms, FEV1, BMI, CSS-SHR, and otherwise as percentage (%).
Definition of abbreviations: FEV1 = Forced expiratory volume in one second;
BMI = Body mass index; CSS-SHR = the Chemical sensitivity scale for
sensory hyperreactivity.
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ing habits. Women reported exercise as a trigger factor
significantly more than men (p < 0.05); otherwise, there
were no gender differences in reported trigger factors.
Questionnaires
CSS-SHR
The mean (SD) CSS-SHR score for the whole group was
43.7 (7.9). There were no differences in the scores be-
tween men and women. The patients were divided into
two groups according to the cut-off value for CSS-SHR:
those who had a score of ≥ 43 points (high score) and
those with lower scores (low score). Forty-seven pa-
tients (57%; 6 men) had a score of ≥ 43 points. There
were no differences in the NHP and the JSC-60 between
patients with high and low scores for the CSS-SHR. For
the SF-36, patients with high CSS-SHR-scores reported
significantly more problems with role limitations due to
psychical problems (p < 0.05) and general health (p < 0.02)
than the low-scoring group.
NHP and SF-36
The HRQOL did not differ between men and women.
Comparison of the frequency distribution of the NHP and
the SF-36 showed that the NHP scores were more skewed
than the SF-36 scores (Figure 1). The prevalence of pa-
tients for the worst possible scores (floor effects) was
higher for the NHP scale (range 0–12.0%) compared with
the SF-36 (range 0–1.2%). There were no differences be-
tween the sexes in floor or ceiling effects. The prevalence
of patients with best possible scores (ceiling effects)
was also higher for the NHP scale (range 28.9-73.5%)
than for the SF-36 score (range 1.2-24.1%). All domains
in the two instruments were statistically reliable, with α
values of > 0.70, except for energy as assessed by the
NHP (α = 0.69). The SF-36 showed the highest reliability
of the two instruments, attaining α values of 0.95 for
bodily pain and 0.91 for physical functioning (Table 3).
The levels of association between the scores for corre-
sponding dimensions on both questionnaires are shown in
Figure 1. High correlations (r > 0.70) were found betweencomparable subscales of the two instruments in all areas
except for social isolation/social functioning (r = 0.29).
As Table 4 shows, the patients reported significantly
lower HRQOL than the reference group in the NHP ques-
tionnaire for emotional reactions, energy, physical mobility
and pain. There were no differences between patients and
the reference group for social isolation and sleep. In the SF-
36, patients reported significantly lower HRQOL than the
reference group, in all dimensions of the questionnaire.
JCS-60
Two patients did not answer the JCS-60 because of diffi-
culty understanding the questions. The patients reported
most frequently using optimistic, self-reliant, and confron-
tational coping methods. The methods they used least were
palliative and emotive coping. Women used significantly
more optimistic coping than men (p < 0.05); otherwise
there were no gender differences. All subscales were statis-
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Figure 1 Frequency distribution of scores on comparable domains of the NHP (left panel) and the SF-36 (middle panel). Right panel
shows correlation of comparable domains of the NHP and the SF-36. *** p < 0.001; ** p < 0.01.
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Table 3 Floor and ceiling effect and Cronbach’s α values in comparable domains of the NHP and the SF-36 scales
(n=83)
NHP Floor Ceiling α values* SF-36 Floor Ceiling α values*
Emotional reactions 0 28.9 0.76 Mental health 0 2.4 0.80
Energy 12.0 44.6 0.69 Vitality 0 1.2 0.88
Physical mobility 0 55.4 0.71 Physical functioning 0 6.0 0.91
Social isolation 1.2 73.5 0.71 Social functioning 1.2 21.7 0.86
Pain 0 51.8 0.89 Bodily pain 1.2 24.1 0.95
Data are presented as percentages *Cronbach’s α values.
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coping styles are shown in Table 5.
When matched for norm values, the patients used sig-
nificantly more optimistic and confrontational coping
and less emotive coping. There were no differences be-
tween patients and the reference group in the other cop-
ing styles (self-reliant, fatalistic, evasive, supportive, and
palliative) (Table 4).Table 4 Comparisons of NHP, SF-36 and JCS-60 mean
scores between patients with SHR and reference values
Instruments and
scales
Study group Reference values P-values
Mean scores (SD) Mean scores (SD)
NHP (n = 83)
Emotional reactions 81.5 (22.0) 89.0 (2.5) 0.002
Energy 69.0 (33.9) 83.0 (6.6) <0.001
Physical mobility 89.2 (14.7) 93.2 (5.3) 0.02
Social isolation 90.0 (20.6) 94.3 (1.9) 0.06
Pain 78.3 (30.2) 91.0 (5.3) <0.001
Sleep 75.3 (30.4) 81.9 (6.5) 0.06
SF-36 (n = 83)
Mental health 69.2 (18.0) 80.0 (1.2) <0.001
Vitality 48.6 (24.5) 67.4 (2.4) <0.001
Physical functioning 74.2 (22.6) 82.4 (7.7) 0.002
Social functioning 68.9 (26.7) 87.3 (1.7) <0.001
Bodily pain 60.3 (29.4) 70.0 (4.1) 0.004
Role-physical 58.7 (41.2) 78.2 (8.5) <0.001
Role-emotional 69.9 (38.5) 83.6 (4.4) 0.002
General health 50.4 (23.7) 71.9 (5.3) <0.001
JCS-60 (n = 81)
Optimistic 1.84 (0.6) 1.59 (0.1) <0.001
Self-reliant 1.58 (0.6) 1.60 (0.1) 0.72
Confrontational 1.83 (0.6) 1.60 (0.1) 0.001
Fatalistic 1.13 (0.6) 1.26 (0.1) 0.06
Evasive 1.19 (0.5) 1.11 (0.1) 0.19
Supportive 1.19 (0.6) 1.27 (0.2) 0.26
Palliative 1.03 (0.5) 0.97 (0.1) 0.28
Emotive 0.82 (0.5) 1.02 (0.2) 0.001Discussion
The main results in the present study can be summarized
as follows. First, the results indicate that the SF-36 scores
were less skewed and more homogeneously distributed
than the NHP scores. The SF-36 showed less floor and
ceiling effects compared with the NHP. The SF-36 was also
better for discriminating between patients with high and
low CSS-SHR scores with regard to role limitations due to
psychical problems and general health. The reliability
standard for both questionnaires was satisfactory. No gen-
der differences in HRQOL were measured with the two in-
struments. Second, the most commonly used coping styles
were optimistic, self-reliant, and confrontational coping.
Women used optimistic coping significantly more than
men. Third, patients with SHR had significantly higher im-
pairment in several dimension of HRQOL compared with
the reference group. Further, the patients used optimistic
and confrontational coping more and emotive coping less,
compared with the reference group.
Both the NHP and the SF-36 have been compared in
several studies in patients with different diseases [8,9]. The
NHP has been used in patients with SHR [3,15], but the
SF-36 has never been used in this group of patients. To as-
sess the utility of these instruments as a general outcome
measure of HRQOL, different criteria have to be taken
into consideration. It has to be quick and easy to use. Both
HRQOL questionnaires fulfilled these criteria, taking
about 10 min to complete. The instrument should also be
acceptable to respondents with few missing values, which
was indicated with the high response rate of 72% in the
present study, and showing only one or few missing values
among the participants in both questionnaires. Further,
the availability and the cost of using a questionnaire are
also important factors. Some advantages with the NHP are
that it is readily available and inexpensive to use. The SF-
36, on the other hand, is strictly copyrighted, and is rather
expensive to administer because of a user fee [45].
The patients NHP and SF-36 scores differed to the
same extent from the reference values, with significantly
lower scores (more difficulties) in comparable domains:
emotional reactions/mental health, energy/vitality, phys-
ical mobility/functioning, and pain/bodily pain. This is
in line with a study in patients with SHR and in a study
Table 5 The Jalowiec Coping Scale-60 (JCS-60) for women and men (n=81)
Scales Total (n=81) Women (n=68) Men (n=13) P-values Chronbach’s α
Mean (SD) Mean (SD) Mean (SD)
Optimistic 1.84 (0.6) 1.90 (0.5) 1.51 (0.6) 0.03 0.76
Self-reliant 1.58 (0.6) 1.61 (0.7) 1.42 (0.5) 0.19 0.75
Confrontational 1.83 (0.6) 1.83 (0.6) 1.82 (0.4) 0.61 0.82
Fatalistic 1.13 (0.6) 1.17 (0.6) 0.90 (0.7) 0.16 0.55
Evasive 1.19 (0.5) 1.20 (0.5) 1.12 (0.4) 0.63 0.72
Supportive 1.19 (0.6) 1.16 (0.6) 1.32 (0.6) 0.40 0.59
Palliative 1.03 (0.5) 1.07 (0.5) 0.81 (0.5) 0.06 0.58
Emotive 0.82 (0.5) 0.85 (0.5) 0.66 (0.5) 0.33 0.62
Total score 1.33 (0.4) 1.35 (0.4) 1.20 (0.4) 0.11 0.91
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[15,46]. In social isolation/functioning, the results were
different, with NHP scores similar to normative data and
SF-36 scores significantly lower. The result in social isola-
tion is in contrast to a longitudinal study in patients with
SHR, showing a greater impairment in social isolation,
compared with reference values [3]. There were no differ-
ences from reference values in sleep, the other NHP score.
All other SF-36 scores were also lower and differed signifi-
cantly from reference values, social functioning, role-
physical, role-emotional, and general health.
The present NHP results showed a higher prevalence of
ceiling effect (indicating best possible quality of life) in all
dimensions compared with the SF-36 results, but also a
higher prevalence of floor effects in energy (indicating low-
est possible quality of life). Otherwise, there were minor
floor effects in both the NHP and the SF-36. This is in ac-
cordance with other studies in patients with chronic limb
ischemia [8,47] and in patients with chronic obstructive dis-
ease [48], which showed fewer ceiling and floor effects in
the SF-36 compared with the NHP. The advantages with
the SF-36 may depend on each item having different pos-
sible scores, whereas the NHP items are dichotomous with
only a yes/no alternative, providing more possibilities for
results at the extreme ends of both good and ill health. To
use a score with only a yes/no alternative may also make it
difficult to show improvement over time. The findings of
Chronbach’s coefficient α values of ≥ 0.70 in all but one di-
mensions of HRQOL implies good internal consistency for
both questionnaires in accordance with earlier findings
[8,47], but the SF-36 seems more preferable because it has
the highest α values.
As mentioned, the CSS-SHR questionnaire can be used
to quantify self-reported sensitivity to chemicals and scents
in the course of daily activities [32]. Our results showed
that patients with high CSS-SHR score reported signifi-
cantly more problems with role limitations due to psychical
problems and general health than those with low CSS-SHR
score, measured with the SF-36. This is in line with Brownet al., showing the SF-36 to be more sensitive than the
NHP in detecting the impact of breathlessness in patients
after a myocardial infarction [46]. In contrast, Wann-
Hansson et al. demonstrated that patients with critical leg
ischemia had more problems with pain and physical mobil-
ity before revascularization than those with intermittent
claudication, measured with the NHP [8]. Similar results
have been found in patients with chronic limb ischemia,
showing NHP to be more sensitive in detecting problems
with pain and psychical mobility [47]. Nevertheless, Prieto
et al. found that both instruments are similar in discrimin-
ating among different levels of respiratory impairment [48].
However, the SF-36 seems to have more validity in dis-
criminating among levels of chemical sensitivity in patients
with SHR. The SF-36 results are less skewed and more
homogeneously distributed, which may suggest that it is
more sensitive to explain HRQOL in patients with SHR,
with respect to psychical problems and general health.
The patients in the present study used optimistic and
confrontational coping significantly more and emotive cop-
ing significantly less often than the reference values. This is
in line with the results of Lindqvist et al., who found that
people with kidney transplants used optimistic coping sig-
nificantly more and emotive coping significantly less often
than the general population [41]. Further, the most fre-
quently used coping styles among the patients were opti-
mistic, self-reliant and confrontational. The two least used
coping styles were palliative and emotive. This is in line
with results in patients on continuous ambulatory periton-
eal dialysis [40], people with kidney transplants [41], and
patients with myocardial infarction (MI) [13]. Kristofferzon
et al. found that over a 12-month period the most used
coping methods after an MI were optimistic, self-reliant
and confrontational and the least used methods were pallia-
tive and emotive [25]. The Chronbach’s coefficient α values
of ≥ 0.70 was only found in four out of eight coping styles
(optimistic, self-reliant, confrontational and evasive). The
results are in accordance with a Swedish population study
[26] and in patients after an MI [13].
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Some limitations of this study were the small sample size
and the selection of participants from only one allergy spe-
cialist clinic. Further, the study consisted of mainly female
patients, which may limit the generalizability of the re-
sults. All patients who fulfilled the inclusion criteria’s were
selected during a specific period. Hence, the study com-
prised only 15.6% male patients. This is, however, in ac-
cordance with earlier studies in patients with SHR, which
showed a predominance of women [2,34]. Another limita-
tion was having participants complete the questionnaires
at home because this meant we did not know whether the
questionnaires were answered without any external influ-
ences. To reduce the risk of occurring and to confirm the
present results, a study is needed that includes a larger
group of patients with SHR from where the patients are
seen in different clinical settings, and having them
complete the questionnaires in a clinical setting. In
addition, longitudinal studies are required to examine
HRQOL and coping in patients with SHR.
To be able to test-retest its reproducibility, an instru-
ment has to be completed twice. Another limitation of
the present study was that the questionnaires were only
answered once, and therefore we were not able to assess
the reproducibility of the questionnaires. However, in
most respects, studies for group-level application have
shown good reproducibility for the CSS-SHR [32], NHP
and SF-36 [9,36,47]. On the other hand, no study con-
cerning test-retest reproducibility of the JCS-60 has been
found in the literature, and a future challenge would be
to conduct such studies in healthy control subjects and
in patients with different diseases.
In this study we only used generic questionnaires to
measure HRQOL. One general recommendation is to
use a generic quality of life questionnaire to compare
results from different diseases and conditions. Disease-
specific scales are required to discriminate between
levels of severity of conditions or diseases and to
detect important clinical changes. Therefore, a recom-
mendation is often made to use both a generic ques-
tionnaire and a disease-specific questionnaire to obtain
a HRQOL outcome [45]. However, no currently ac-
cepted disease-specific questionnaire exists for patients
with SHR. Further research has to be conducted to de-
velop an instrument to measure HRQOL in patients
with SHR.
A further limitation of the study may be that we only
used part A of the JCS-60 questionnaire. However,
this is in accordance with studies in patients with MI
and chronic illness [13,25,49]. As mentioned before,
studies have shown a strong correlation between part
A and B, which may suggest a risk that the use and effi-
ciency components measure the same aspect of coping
[40,41].Conclusions
The current findings showed that both the NHP and the
SF-36 were reliable instruments; but the results suggest
that the SF-36 is a more sensitive method than the NHP
to elucidate HRQOL in patients with SHR. Patients with
SHR experienced a lower HRQOL, and used more opti-
mistic and confrontational coping, compared with nor-
mative data. They followed the Western tradition of
preferring problem-focused coping strategies to palliative
and emotive strategies.
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